Related Experiment Video
Updated: Nov 9, 2025
11:44
Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
Published on: August 29, 2016
11.2K
Novel mouse model expands potential human α-cell research.
Theodore Dos Santos1,2, Patrick E MacDonald1,2
1Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada.
Islets
|April 15, 2021
Summary
Researchers developed a glucagon-deficient mouse model. This model preserves glucagon-like peptide-1 (GLP-1) and GLP-2 secretion, offering a valuable tool for studying human islet transplantation and glucagon responses in diabetes research.
Area of Science:
- Endocrinology
- Diabetes Research
- Islet Biology
Background:
- Glucagon plays a crucial role in glucose homeostasis.
- Understanding glucagon's function is vital for diabetes research.
- Current models often lack the ability to study specific aspects of glucagon physiology.
Purpose of the Study:
- To create a novel mouse model for studying glucagon's role in metabolic diseases.
- To investigate human islet transplantation and glucagon secretion.
- To provide a resource for advancing diabetes research.
Main Methods:
- Generation of a glucagon knock-out mouse model.
- Assessment of preserved glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) secretion.
- Evaluation of the model's utility in studying transplanted human islets.
Main Results:
- Successfully generated a glucagon knock-out mouse.
- Confirmed preserved GLP-1 and GLP-2 secretion in the absence of glucagon.
- Demonstrated the model's suitability for studying human islet transplantation and glucagon responses.
Conclusions:
- The developed glucagon knock-out mouse is a significant advancement for diabetes research.
- This model facilitates improved studies of human islet transplantation.
- It offers unprecedented insights into human alpha-cell function and glucagon's role in metabolic regulation.
